Stoke Therapeutics focuses on developing antisense oligonucleotide medicines for the treatment of genetic diseases.
Business Model:
Revenue: $9.1M
Employees: 51-200
Address: 45 Wiggins Avenue
City: Bedford
State: MA
Zip: 01730
Country: US
Stoke Therapeutics focuses on developing antisense oligonucleotide medicines for the treatment of genetic diseases.
Contact Phone:
+17814308200
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/19/2019
IPO Valuation:
$566M
Ticker Symbol:
STOK
IPO Price:
$18/share
Amount Raised:
$163M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2018 | Series A | 1 | $40M |
Apple Tree Partners Apple Tree Partners |
11/2020 | Post-IPO Equity | $105.1M | 10/2018 | Series B | 9 | $90M |
Alexandria Venture Investments Apple Tree Partners Cormorant Asset Management Janus Henderson Investors Perceptive Advisors RA Capital Management Redmile Group RTW Investments LLC Sphera Funds Management Alexandria Venture Investments Apple Tree Partners Cormorant Asset Management Janus Henderson Investors Perceptive Advisors RA Capital Management Redmile Group RTW Investments LLC Sphera Funds Management |
6/2019 | IPO | $142M |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|